31588368|t|Alzheimer's Disease and Its Potential Alternative Therapeutics.
31588368|a|Alzheimer's Disease (AD) is a chronic neurodegenerative disease that affects over 5 million individuals in the United States alone. Currently, there are only two kinds of pharmacological interventions available for symptomatic relief of AD; Acetyl Cholinesterase Inhibitors (AChEI) and N-methyl-D-aspartic Acid (NMDA) receptor antagonists and these drugs do not slow down or stop the progression of the disease. Several molecular targets have been implicated in the pathophysiology of AD, such as the tau (tau) protein, Amyloid-beta (Abeta), the Amyloid Precursor Protein (APP) and more and several responses have also been observed in the advancement of the disease, such as reduced neurogenesis, neuroinflammation, oxidative stress and iron overload. In this review, we discuss general features of AD and several small molecules across different experimental AD drug classes that have been studied for their effects in the context of the molecular targets and responses associated with the AD progression. These drugs include: Paroxetine, Desferrioxamine (DFO), N-acetylcysteine (NAC), Posiphen/-(-)Phenserine, JTR-009, Carvedilol, LY450139, Intravenous immunoglobulin G 10%, Indomethacin and Lithium Carbonate (Li2CO3).
31588368	0	19	Alzheimer's Disease	Disease	MESH:D000544
31588368	64	83	Alzheimer's Disease	Disease	MESH:D000544
31588368	85	87	AD	Disease	MESH:D000544
31588368	102	127	neurodegenerative disease	Disease	MESH:D019636
31588368	301	303	AD	Disease	MESH:D000544
31588368	549	551	AD	Disease	MESH:D000544
31588368	565	568	tau	Gene	4137
31588368	570	573	tau	Gene	4137
31588368	584	596	Amyloid-beta	Gene	351
31588368	598	603	Abeta	Gene	351
31588368	610	635	Amyloid Precursor Protein	Gene	351
31588368	762	779	neuroinflammation	Disease	MESH:D000090862
31588368	802	815	iron overload	Disease	MESH:D019190
31588368	864	866	AD	Disease	MESH:D000544
31588368	925	927	AD	Disease	MESH:D000544
31588368	1056	1058	AD	Disease	MESH:D000544
31588368	1093	1103	Paroxetine	Chemical	MESH:D017374
31588368	1105	1120	Desferrioxamine	Chemical	MESH:D003676
31588368	1122	1125	DFO	Chemical	MESH:D003676
31588368	1128	1144	N-acetylcysteine	Chemical	MESH:D000111
31588368	1146	1149	NAC	Chemical	MESH:D000111
31588368	1152	1160	Posiphen	Chemical	MESH:C092280
31588368	1165	1175	Phenserine	Chemical	MESH:C092280
31588368	1177	1184	JTR-009	Chemical	MESH:C587862
31588368	1186	1196	Carvedilol	Chemical	MESH:D000077261
31588368	1198	1206	LY450139	Chemical	MESH:C484278
31588368	1242	1254	Indomethacin	Chemical	MESH:D007213
31588368	1259	1276	Lithium Carbonate	Chemical	MESH:D016651
31588368	1278	1284	Li2CO3	Chemical	MESH:D016651
31588368	Negative_Correlation	MESH:C484278	MESH:D000544
31588368	Negative_Correlation	MESH:C587862	MESH:D000544
31588368	Association	MESH:D000544	4137
31588368	Negative_Correlation	MESH:D003676	MESH:D000544
31588368	Association	MESH:D000544	351
31588368	Association	MESH:D000111	MESH:D000544
31588368	Negative_Correlation	MESH:D000077261	MESH:D000544
31588368	Negative_Correlation	MESH:C092280	MESH:D000544
31588368	Negative_Correlation	MESH:D007213	MESH:D000544
31588368	Negative_Correlation	MESH:D017374	MESH:D000544
31588368	Association	MESH:D016651	MESH:D000544

